{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:46:59Z","timestamp":1795024019579,"version":"4.10.2"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jneuroim.2024.578312","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:26:11Z","timestamp":1707132371000},"page":"578312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype"],"prefix":"10.1016","volume":"388","author":[{"given":"Xiaoyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian R.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McKeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Zekeridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jneuroim.2024.578312_bb0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/WNO.0000000000000593","article-title":"Optic disc edema in glial fibrillary acidic protein autoantibody-positive meningoencephalitis","volume":"38","author":"Chen","year":"2018","journal-title":"J. Neuroophthalmol."},{"issue":"6","key":"10.1016\/j.jneuroim.2024.578312_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200153","article-title":"Trigeminal nerve involvement in bulbar-onset anti-IgLON5 disease","volume":"10","author":"Cluse","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"2","key":"10.1016\/j.jneuroim.2024.578312_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ophtha.2019.09.012","article-title":"Collapsin response-mediator protein 5\u2013associated retinitis, vitritis, and optic disc edema","volume":"127","author":"Cohen","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578312_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578312_bb0025","doi-asserted-by":"crossref","first-page":"19536","DOI":"10.1038\/s41598-021-97768-5","article-title":"Spatiotemporal expression of IgLON family members in the developing mouse nervous system","volume":"11","author":"Fearnley","year":"2021","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.jneuroim.2024.578312_bb0030","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2024.578312_bb0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.jneuroim.2024.578312_bb0040","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"2","key":"10.1016\/j.jneuroim.2024.578312_bb0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease","volume":"146","author":"Gr\u00fcter","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jneuroim.2024.578312_bb0050","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"6","key":"10.1016\/j.jneuroim.2024.578312_bb0055","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.jneuroim.2024.578312_bb0060","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1007\/s00415-022-11262-0","article-title":"Motor-neuron-disease-like phenotype associated with IgLON5 disease","volume":"269","author":"Sista","year":"2022","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578312_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/WNO.0b013e3182699b2a","article-title":"Pancreatic neuroendocrine paraneoplastic optic neuropathy: confirmation with antibody to optic nerve and hepatic metastasis","volume":"33","author":"Slamovits","year":"2013","journal-title":"J. Neuroophthalmol."},{"issue":"23","key":"10.1016\/j.jneuroim.2024.578312_bb0070","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM198912073212307","article-title":"Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells","volume":"321","author":"Thirkill","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2024.578312_bb0075","series-title":"American Academy of Neurology Annual Meeting(P5-5.028)","article-title":"Anti-IgLON-5 associated neurological disease presenting with bilateral optic neuritis, orthostatic intolerance, sleep-related movements in setting of testicular mass: expanding clinical phenotypes in the disease","author":"Varma-Doyle","year":"2023"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:44:04Z","timestamp":1759049044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572824000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":15,"alternative-id":["S0165572824000304"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578312","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578312"}}